These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

400 related articles for article (PubMed ID: 16339677)

  • 1. Treatment of hepatitis C virus infection in thalassemia.
    Butensky E; Pakbaz Z; Foote D; Walters MC; Vichinsky EP; Harmatz P
    Ann N Y Acad Sci; 2005; 1054():290-9. PubMed ID: 16339677
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chronic hepatitis C virus infection in renal transplant: treatment and outcome.
    Sharma RK; Bansal SB; Gupta A; Gulati S; Kumar A; Prasad N
    Clin Transplant; 2006; 20(6):677-83. PubMed ID: 17100715
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of chronic hepatitis C virus infection with interferon alfa and ribavirin: sustained response in two patients with transfusion dependent thalassaemia.
    Hamidah A; Yong JF; Zulkifli HI; Jamal R
    Med J Malaysia; 2002 Sep; 57(3):353-6. PubMed ID: 12440276
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Once-weekly epoetin alfa improves anemia and facilitates maintenance of ribavirin dosing in hepatitis C virus-infected patients receiving ribavirin plus interferon alfa.
    Dieterich DT; Wasserman R; Bräu N; Hassanein TI; Bini EJ; Bowers PJ; Sulkowski MS
    Am J Gastroenterol; 2003 Nov; 98(11):2491-9. PubMed ID: 14638354
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatic iron overload does not prevent a sustained virological response to interferon-alpha therapy: a long term follow-up study in hepatitis C-infected patients with beta thalassemia major.
    Sievert W; Pianko S; Warner S; Bowden S; Simpson I; Bowden D; Locarnini S
    Am J Gastroenterol; 2002 Apr; 97(4):982-7. PubMed ID: 12003436
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alpha-interferon treatment of chronic hepatitis C after bone marrow transplantation for homozygous beta-thalassemia.
    Giardini C; Galimberti M; Lucarelli G; Polchi P; Angelucci E; Baronciani D; Erer B; Gaziev D; Piga A; Di Gregorio F; Romeo MA; Mangiagli A; Petrelli E; Muretto P
    Bone Marrow Transplant; 1997 Nov; 20(9):767-72. PubMed ID: 9384479
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatitis C virus therapy in liver transplant recipients: response predictors, effect on fibrosis progression, and importance of the initial stage of fibrosis.
    Roche B; Sebagh M; Canfora ML; Antonini T; Roque-Afonso AM; Delvart V; Saliba F; Duclos-Vallee JC; Castaing D; Samuel D
    Liver Transpl; 2008 Dec; 14(12):1766-77. PubMed ID: 19025933
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anemia in the treatment of hepatitis C virus infection.
    Sulkowski MS
    Clin Infect Dis; 2003; 37 Suppl 4():S315-22. PubMed ID: 14582000
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A randomized, double-blind, placebo-controlled dose-escalation trial of merimepodib (VX-497) and interferon-alpha in previously untreated patients with chronic hepatitis C.
    McHutchison JG; Shiffman ML; Cheung RC; Gordon SC; Wright TL; Pottage JC; McNair L; Ette E; Moseley S; Alam J
    Antivir Ther; 2005; 10(5):635-43. PubMed ID: 16152757
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Interferon-alpha and ribavirin combination therapy for co-infection of hepatitis C virus and human immunodeficiency virus].
    Zheng YH; He Y; Yang X; Gong GZ; Zhou HY; Zhang CY; Zhou W; Huang L; Ding PP; Li H
    Zhonghua Gan Zang Bing Za Zhi; 2005 Oct; 13(10):741-4. PubMed ID: 16248945
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Therapy with interferon plus ribavirin in hemodialysis patient with PCR-positive viral hepatitis C].
    Arambarri M; Fernández Lucas M; Echarri R; Teruel JL; Alarcón C; Merino JL; Ortuño J
    Nefrologia; 2004; 24 Suppl 3():39-42. PubMed ID: 15219067
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combination therapy with interferon and ribavirin for chronic hepatitis C infection in beta-thalassaemia major.
    Saffar MJ; Saffar H; Khalilian AR; Naqshvar F
    East Mediterr Health J; 2009; 15(4):785-91. PubMed ID: 20187529
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dynamics of serum metabolites in patients with chronic hepatitis C receiving pegylated interferon plus ribavirin: a metabolomics analysis.
    Saito T; Sugimoto M; Igarashi K; Saito K; Shao L; Katsumi T; Tomita K; Sato C; Okumoto K; Nishise Y; Watanabe H; Tomita M; Ueno Y; Soga T
    Metabolism; 2013 Nov; 62(11):1577-86. PubMed ID: 23953890
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Treatment of chronic hepatitis C in special groups].
    Bourlière M; Halfon P; Portal I
    Gastroenterol Clin Biol; 2002 Apr; 26 Spec No 2():B238-47. PubMed ID: 12180296
    [No Abstract]   [Full Text] [Related]  

  • 15. [Treatment for chronic hepatitis C, more opportunity, more challenge].
    Wei L
    Zhonghua Gan Zang Bing Za Zhi; 2009 Jul; 17(7):481-3. PubMed ID: 19912676
    [No Abstract]   [Full Text] [Related]  

  • 16. [Steroids, interferon-alpha and ribavirin treatment of cryoglobulinemic glomerulonephritis concurrent with HCV infection].
    Guarnieri A; Marazzi F; Giorgi MP; Canepari G; Pino C; Moggia E; Manca A; Ghezzi PM
    G Ital Nefrol; 2002; 19(1):79-81. PubMed ID: 12165950
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Difficult-to-treat patient with chronic hepatitis C: a challenge in clinical practice].
    Dou XG
    Zhonghua Gan Zang Bing Za Zhi; 2009 Jul; 17(7):486-7. PubMed ID: 19912678
    [No Abstract]   [Full Text] [Related]  

  • 18. Hemolytic anemia induced by ribavirin therapy in patients with chronic hepatitis C virus infection: role of membrane oxidative damage.
    De Franceschi L; Fattovich G; Turrini F; Ayi K; Brugnara C; Manzato F; Noventa F; Stanzial AM; Solero P; Corrocher R
    Hepatology; 2000 Apr; 31(4):997-1004. PubMed ID: 10733558
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatic iron accumulation is associated with disease progression and resistance to interferon/ribavirin combination therapy in chronic hepatitis C.
    Fujita N; Sugimoto R; Urawa N; Araki J; Mifuji R; Yamamoto M; Horiike S; Tanaka H; Iwasa M; Kobayashi Y; Adachi Y; Kaito M
    J Gastroenterol Hepatol; 2007 Nov; 22(11):1886-93. PubMed ID: 17914965
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factors accelerating liver fibrosis progression in renal transplant patients receiving ribavirin monotherapy for chronic hepatitis C.
    Kamar N; Boulestin A; Selves J; Esposito L; Sandres-Saune K; Stébenet M; Chatelut E; Durand D; Rostaing L; Izopet J
    J Med Virol; 2005 May; 76(1):61-8. PubMed ID: 15778976
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.